NCT03800797View on ClinicalTrials.gov

Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 25, 2015

Primary Completion Date

December 10, 2015

Study Completion Date

December 10, 2015

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Loxoprofen sodium hydrogel patch

100 mg per day

DRUG

Loxoprofen sodium tablet

60 mg t.i.d.

Trial Locations (1)

Unknown

Department of Rheumatology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT03800797 - Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter